By Counterforce Health Team in Ocrevus (ocrelizumab) —

Renewing Ocrevus (Ocrelizumab) Approval with Cigna in Pennsylvania: Complete Timeline and Documentation Guide

Answer Box: Renewing Your Ocrevus Approval

To renew Ocrevus (ocrelizumab) with Cigna in Pennsylvania: Submit the Ocrevus CCRD Prior Authorization Form via CoverMyMeds or fax to 855-840-1678 with updated clinical records, MRI reports, lab results (CBC, HBV screening), and neurologist assessment showing continued response or disease stability. Start 30-45 days before your current approval expires. If denied, you have 180 days to file internal appeals, then can request Pennsylvania's independent external review within 4 months of final denial.

Table of Contents

Renewal Triggers: When to Start

Cigna typically approves Ocrevus for 6-month periods initially, then may extend to 12 months for stable patients. Start your renewal process 30-45 days before expiration to avoid gaps.

Signs to Start Early

  • MRI scheduled within 60 days of renewal deadline
  • Recent infections or hospitalizations requiring documentation
  • EDSS changes (worsening or improvement) since last approval
  • Lab abnormalities that need follow-up testing
  • Plan changes for the upcoming year
Note: Cigna processes standard prior authorization requests within 5 business days, but complex cases or missing documentation can cause delays.

Evidence Update: What Your Doctor Needs

Your neurologist must document continued medical necessity and treatment response. Here's what Cigna requires for renewal:

Clinical Response Documentation

  • EDSS scores compared to baseline and previous assessments
  • Relapse frequency over the past 6-12 months
  • Functional status and quality of life measures
  • Adherence to infusion schedule (every 6 months)

Safety Monitoring Results

Required lab work before each infusion:

  • Complete blood count with differential
  • Liver function tests
  • Hepatitis B surface antigen and core antibody
  • Immunoglobulin levels (if recurrent infections)

MRI requirements:

  • Annual brain and spinal cord MRI
  • Documentation of new or enlarging T2 lesions
  • Gadolinium-enhancing lesion count
  • Comparison to baseline and prior scans
Clinician Corner: Document treatment response using objective measures. "Stable disease" is acceptable for renewal if supported by MRI stability and lack of new relapses. Include specific EDSS scores and dates of assessments.

Renewal Packet: Required Documents

Core Documentation Checklist

  • Ocrevus CCRD Prior Authorization Form (completed by neurologist)
  • Updated clinical notes from neurologist visit within 90 days
  • Recent MRI reports (brain and spine, within 12 months)
  • Laboratory results (CBC, LFTs, HBV screening within 30 days)
  • EDSS assessment with comparison to baseline
  • Prior therapy documentation (if new patient or changing from another DMT)

Medical Necessity Letter Components

When clinical notes aren't sufficient, request a separate letter including:

  1. Confirmed MS diagnosis with ICD-10 code G35
  2. Disease phenotype (relapsing-remitting, secondary progressive, or primary progressive)
  3. Prior DMT failures or contraindications to first-line therapies
  4. Current disease activity and treatment response
  5. Monitoring plan and safety considerations

Timeline: Submission to Decision

Step Timeframe Action Required
Submit renewal 30-45 days before expiration Neurologist submits via CoverMyMeds or fax
Initial review 5 business days Cigna reviews for completeness
Clinical review 72 hours (standard) or 24 hours (urgent) Medical director assessment
Decision notification Within 15 days total Approval or denial letter sent
Appeal window 180 days from denial File internal appeal if denied

Expedited Review Process

Call Cigna at 800-882-4462 for urgent requests when:

  • Current approval expires within 72 hours
  • Patient experiencing active relapse
  • Delay would cause serious health consequences

If Coverage Lapses

Immediate Steps

  1. Contact Accredo Specialty Pharmacy (Cigna's preferred specialty provider) at 800-803-2523
  2. Request prior authorization exception citing urgent medical need
  3. Ask about bridge therapy or temporary supply options
  4. Document the gap for potential retroactive coverage

Bridge Options to Discuss

  • Manufacturer assistance programs through Genentech Access Solutions
  • Hospital charity care if infusion needed emergently
  • Provider samples (limited availability)
  • Appeal for retroactive coverage once renewal is approved
From Our Advocates: We've seen patients successfully argue for retroactive coverage when lapses occurred due to administrative delays. Document all communications and keep receipts for any out-of-pocket costs during the gap period.

Annual Plan Changes

What to Verify Each Year

  • Formulary status - Is Ocrevus still covered?
  • Tier placement - Has your copay/coinsurance changed?
  • Prior authorization requirements - Any new criteria?
  • Specialty pharmacy network - Is Accredo still preferred?
  • Provider network - Is your neurologist still in-network?

Check these resources annually:

Appeals Process in Pennsylvania

Pennsylvania offers robust appeal rights with a new state-supervised external review program launched in 2024.

Internal Appeals (First Step)

  • Timeline: File within 180 days of denial
  • Process: Submit via Cigna member portal or mail
  • Decision: 30 days for standard, 72 hours for expedited
  • Required: Copy of denial letter, supporting medical records

Pennsylvania External Review (After Internal Appeals)

  • Eligibility: Must have Final Adverse Benefit Determination letter
  • Timeline: 4 months to request after final internal denial
  • Success rate: Approximately 50% of appeals overturned in 2024
  • Process: Submit online at pa.gov external review portal
  • Decision: 45 days for standard, 72 hours for expedited
  • Cost: Free to consumers

Required Documents for Appeals

  • Original denial letter(s)
  • Complete medical records supporting medical necessity
  • Peer-reviewed literature on Ocrevus efficacy
  • Neurologist attestation letter
  • Treatment timeline and response documentation

Personal Tracker Template

Renewal Checklist

Current approval expires: ___________
Renewal submission deadline: ___________
Next MRI scheduled: ___________
Last EDSS score: _______ Date: _______
Recent labs completed: ___________

Key Contacts

  • Neurologist office: ___________
  • Cigna member services: 800-244-6224
  • Accredo specialty pharmacy: 800-803-2523
  • PA Insurance Department: 877-881-6388

Documentation Status

  • PA form completed by neurologist
  • Clinical notes updated (within 90 days)
  • MRI reports current (within 12 months)
  • Lab results current (within 30 days)
  • Prior therapy documentation complete

Counterforce Health helps patients navigate complex prior authorization requirements for specialty medications like Ocrevus. Our platform analyzes denial letters and creates evidence-backed appeals tailored to each payer's specific criteria, helping patients get the treatments they need faster. Learn more about our services.

FAQ

How long does Cigna take to approve Ocrevus renewals?
Standard renewals are processed within 5 business days if all documentation is complete. Complex cases may take up to 15 days.

What if my MRI shows new lesions?
New lesions don't automatically disqualify renewal. Your neurologist should document whether this represents expected disease fluctuation or treatment failure requiring therapy change.

Can I appeal if Cigna requires step therapy for my renewal?
Yes. Document prior DMT failures or contraindications. Pennsylvania's external review has overturned many step therapy requirements when medically inappropriate.

Does Cigna cover both IV Ocrevus and subcutaneous Ocrevus Zunovo?
Both formulations are typically covered. Check current formulary status as coverage may vary by plan.

What if I can't get to Accredo for my specialty pharmacy needs?
Contact Cigna to request a network exception. Some plans allow retail fills before requiring specialty pharmacy transfer.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies vary by plan and may change. Always verify current requirements with your insurance provider and consult your healthcare team for medical decisions. For assistance with appeals in Pennsylvania, contact the Pennsylvania Insurance Department at 877-881-6388.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.